Form 4: IMAX CEO Richard Gelfond Trades Shares

IMAX CEO Richard Gelfond reported transactions involving company stock, including the exercise of stock options and the sale of common shares.

Summary

• Richard L. Gelfond, CEO of IMAX Corp, engaged in stock transactions on April 10, 2026.
• He exercised stock options to acquire 135,046 common shares at a price of $31.40 per share.
• Concurrently, Gelfond sold 135,046 common shares at a price of $37.8158 per share.
• These transactions were made pursuant to a Rule 10b5-1(c) trading plan established on December 9, 2025.
• Following these transactions, Gelfond's beneficial ownership includes 765,002 directly owned common shares.
• His aggregate remaining outstanding options, restricted share units, and common shares are 1,537,045, 231,562, and 765,002, respectively.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it represents routine insider transactions executed under a pre-established plan, with no new strategic information or significant changes in beneficial ownership.

Positives

• The transactions were executed under a pre-arranged 10b5-1 plan, indicating adherence to established trading policies and potentially mitigating insider trading concerns.
• The sale price of $37.8158 per share is higher than the exercise price of $31.40, resulting in a profit on the exercised options.

Negatives

• The CEO sold a significant number of shares (135,046), which could be interpreted negatively by the market, although it was part of a pre-planned strategy.

Risks

• Potential for negative market perception due to the CEO selling shares, even if executed under a 10b5-1 plan.
• The remaining stock options expire on June 7, 2026, which could influence future trading activity.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports on past transactions.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for executives and directors, providing transparency on their holdings and transactions. The use of a 10b5-1 plan by IMAX's CEO is a common practice to diversify holdings or manage personal finances while adhering to insider trading regulations.

Stakeholder Impact

• Shareholders: The sale of shares by the CEO, even under a 10b5-1 plan, might be perceived as a negative signal, potentially impacting short-term stock price sentiment. However, the adherence to a plan suggests a structured approach to personal financial management rather than a reaction to adverse company news.
• Employees: No direct impact mentioned.
• Creditors: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Customers: No direct impact mentioned.

Next Steps

• The remaining stock options held by Mr. Gelfond are set to expire on June 7, 2026.

Key Dates

Keywords

IMAX Corp, Richard L. Gelfond, Form 4, SEC Filing, Stock Options, Common Shares, 10b5-1 Plan, Insider Trading, Beneficial Ownership, CEO Transactions